BioCentury | Jan 15, 2021
Finance

A maturing mid-cap sector could keep funds flowing into biotech

...Hillary Clinton raised the specter of drug pricing controls.Handelsbanken’s...
BioCentury | Jan 9, 2021
Finance

Targeted oncology is having a moment, again

...itself could become a takeout target.Gordon and  Handelsbanken’s...
BioCentury | Oct 15, 2020
Product Development

Lingering questions as Vertex sheds $15B after Phase II setback

...for which consensus estimates were available. And Handelsbanken’s...
BioCentury | Jul 10, 2020
Finance

How buysiders are sizing up commercial launches during the pandemic

...informed. It might be the best launch ever. They probably don’t even need telemedicine,” said Handelsbanken’s...
BioCentury | Jul 10, 2020
Finance

After pouring into biotech in 2Q, will generalists stay or will they go?

...be overweight healthcare.” Astrid Samuelsson, who manages a broad global healthcare fund for Swedish firm Handelsbanken...
...are generalists, and healthcare is really a preferred sector for many of them.” Astrid Samuelsson, Handelsbanken...
BioCentury | Jun 15, 2018
Financial News

Immunovia issues $37.3M in new shares

...in a new share issue of 2.2 million shares at SEK150. Investors included Swedbank Robur, Handelsbanken...
BioCentury | Nov 16, 2017
Financial News

Protein misfolding play Orphazyme prices IPO

...through the sale of 7.5 million shares at DKK 80. Investors included SEB, Vækstfonden, BankInvest, Handelsbanken...
BioCentury | Apr 4, 2017
Financial News

Isofol raises SEK430M in IPO

...rights from Merck KGaA (Xetra:MRK) to the endogenous folate-based biomodulator. Investors in the listing included Handelsbanken...
BioCentury | Jun 6, 2016
Financial News

Swedish Orphan Biovitrum financial update

...into a three-year SEK500 million ($60.1 million) term and SEK500 million revolving facilities agreement with Handelsbanken...
BioCentury | Jul 20, 2015
Financial News

Recipharm financial update

...2015-07-13 Note: Recipharm secured a new five-year SEK1.5 billion ($177.5 million) loan facility from DNB, Handelsbanken...
Items per page:
1 - 10 of 59
BioCentury | Jan 15, 2021
Finance

A maturing mid-cap sector could keep funds flowing into biotech

...Hillary Clinton raised the specter of drug pricing controls.Handelsbanken’s...
BioCentury | Jan 9, 2021
Finance

Targeted oncology is having a moment, again

...itself could become a takeout target.Gordon and  Handelsbanken’s...
BioCentury | Oct 15, 2020
Product Development

Lingering questions as Vertex sheds $15B after Phase II setback

...for which consensus estimates were available. And Handelsbanken’s...
BioCentury | Jul 10, 2020
Finance

How buysiders are sizing up commercial launches during the pandemic

...informed. It might be the best launch ever. They probably don’t even need telemedicine,” said Handelsbanken’s...
BioCentury | Jul 10, 2020
Finance

After pouring into biotech in 2Q, will generalists stay or will they go?

...be overweight healthcare.” Astrid Samuelsson, who manages a broad global healthcare fund for Swedish firm Handelsbanken...
...are generalists, and healthcare is really a preferred sector for many of them.” Astrid Samuelsson, Handelsbanken...
BioCentury | Jun 15, 2018
Financial News

Immunovia issues $37.3M in new shares

...in a new share issue of 2.2 million shares at SEK150. Investors included Swedbank Robur, Handelsbanken...
BioCentury | Nov 16, 2017
Financial News

Protein misfolding play Orphazyme prices IPO

...through the sale of 7.5 million shares at DKK 80. Investors included SEB, Vækstfonden, BankInvest, Handelsbanken...
BioCentury | Apr 4, 2017
Financial News

Isofol raises SEK430M in IPO

...rights from Merck KGaA (Xetra:MRK) to the endogenous folate-based biomodulator. Investors in the listing included Handelsbanken...
BioCentury | Jun 6, 2016
Financial News

Swedish Orphan Biovitrum financial update

...into a three-year SEK500 million ($60.1 million) term and SEK500 million revolving facilities agreement with Handelsbanken...
BioCentury | Jul 20, 2015
Financial News

Recipharm financial update

...2015-07-13 Note: Recipharm secured a new five-year SEK1.5 billion ($177.5 million) loan facility from DNB, Handelsbanken...
Items per page:
1 - 10 of 59